Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer

被引：0
|
作者：
Fang Tan
Marina Mosunjac
Amy L Adams
Beverly Adade
Oleyad Taye
Yijuan Hu
Monica Rizzo
Solomon F Ofori-Acquah
机构：
[1] Emory University School of Medicine,Aflac Cancer Center and Blood Disorders Service, Department of Pediatrics
[2] Grady Memorial Hospital,Department of Pathology and Laboratory Medicine
[3] Emory University School of Medicine,Department of Biostatistics and Bioinformatics
[4] Rollins School of Public Health,Department of Surgery, Division of Surgical Oncology
[5] Emory University,undefined
[6] Emory University School of Medicine,undefined
[7] University of Pittsburgh,undefined
来源：
BMC Cancer | / 14卷
关键词：
ALCAM; African-American; Caucasian; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] CD166/ALCAM IS EXPRESSED IN GLIOBLASTOMA ENDOTHELIAL CELLS AND IS INVOLVED IN THE REGULATION OF GLIOBLASTOMA ANGIOGENESIS THROUGH THE REGULATION OF INTERLEUKIN 8
    Kijima, Noriyuki
    Hosen, Naoki
    Kagawa, Naoki
    Hashimoto, Naoya
    Chiba, Yasuyoshi
    Kinoshita, Manabu
    Sugiyama, Haruo
    Yoshimine, Toshiki
    NEURO-ONCOLOGY, 2013, 15 : 4 - 4
  • [22] ALCAM/CD166 Is a TGF-β-Responsive Marker and Functional Regulator of Prostate Cancer Metastasis to Bone
    Hansen, Amanda G.
    Arnold, Shanna A.
    Jiang, Ming
    Palmer, Trenis D.
    Ketova, Tatiana
    Merkel, Alyssa
    Pickup, Michael
    Samaras, Susan
    Shyr, Yu
    Moses, Harold L.
    Hayward, Simon W.
    Sterling, Julie A.
    Zijlstra, Andries
    CANCER RESEARCH, 2014, 74 (05) : 1404 - 1415
  • [23] SOSTDC1 promotes invasion and liver metastasis in colorectal cancer via interaction with ALCAM/CD166
    Rubén A. Bartolomé
    Laura Pintado-Berninches
    Marta Jaén
    Vivian de Los Ríos
    Juan Ignacio Imbaud
    J. Ignacio Casal
    Oncogene, 2020, 39 : 6085 - 6098
  • [24] SOSTDC1 promotes invasion and liver metastasis in colorectal cancer via interaction with ALCAM/CD166
    Bartolome, Ruben A.
    Pintado-Berninches, Laura
    Jaen, Marta
    de los Rios, Vivian
    Imbaud, Juan Ignacio
    Casal, J. Ignacio
    ONCOGENE, 2020, 39 (38) : 6085 - 6098
  • [25] Activated leukocyte cell adhesion molecule (ALCAM/CD166) is an important clinical and prognostic indicator in pancreatic cancer
    Yang, Y. M.
    Sanders, A. J.
    Dong, X.
    Cui, Y.
    Hao, C.
    Ji, J.
    Jiang, W. G.
    BRITISH JOURNAL OF SURGERY, 2021, 108 : V5 - V5
  • [26] Adhesion molecules, their receptors, and their regulation: Analysis of CD6-activated leukocyte cell adhesion molecule (ALCAM/CD166) interactions
    Bowen, MA
    Aruffo, A
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 795 - 796
  • [27] Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera
    Vaisocherova, Hana
    Faca, Vitor M.
    Taylor, Allen D.
    Hanash, Samir
    Jiang, Shaoyi
    BIOSENSORS & BIOELECTRONICS, 2009, 24 (07): : 2143 - 2148
  • [28] The Cancer Stem Cell Marker CD166/Alcam Regulates Signaling Pathways That Govern Intestinal Epithelial Cell Growth
    Smith, Nicholas R.
    Levin, Trevor G.
    Erickson, Crystal J.
    Bubbers, Emily J.
    Abe, James
    Wong, Melissa H.
    GASTROENTEROLOGY, 2014, 146 (05) : S84 - S84
  • [29] Breast cancer in African-American women
    Newman, LA
    ONCOLOGIST, 2005, 10 (01): : 1 - 14
  • [30] Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
    Kahlert, C.
    Weber, H.
    Mogler, C.
    Bergmann, F.
    Schirmacher, P.
    Kenngott, H. G.
    Matterne, U.
    Mollberg, N.
    Rahbari, N. N.
    Hinz, U.
    Koch, M.
    Aigner, M.
    Weitz, J.
    BRITISH JOURNAL OF CANCER, 2009, 101 (03) : 457 - 464
12345